Never stop a prescribed medication without discussing it with your primary care doctor or urologist first. Many BPH medication side effects are manageable or resolve with time, and suddenly stopping alpha-blockers can cause rebound worsening of urinary symptoms — and in severe cases, trigger acute urinary retention. Your urologist can switch you to an alternative medication with a different side effect profile, adjust the dose, or discuss surgical options if medication is poorly tolerated. Read more in our tamsulosin side effects guide.

Retrograde ejaculation means semen travels backward into the bladder instead of exiting through the urethra during orgasm. It is caused by alpha-blockers (particularly tamsulosin and silodosin) relaxing the bladder neck muscle. It is not harmful and does not affect orgasm quality for most men, but it does cause reduced or absent visible ejaculation and can affect fertility. Switching to alfuzosin often reduces this effect. Read more in our BPH treatment article.

Finasteride lowers DHT by approximately 70%, which can cause erectile dysfunction, reduced libido, and ejaculatory changes in approximately 5–8% of men. In the vast majority of cases, these effects are reversible upon stopping the medication. Post-finasteride syndrome — persistent sexual side effects after stopping — is reported but remains controversial and poorly understood. The risk should be weighed against the benefits of prostate volume reduction. Our finasteride side effects article covers this in detail.

IFIS is a complication during cataract surgery caused by current or previous use of alpha-blockers — especially tamsulosin. The iris becomes floppy and difficult for the surgeon to manage, increasing the risk of surgical complications. If you have ever taken tamsulosin — even years ago — inform your ophthalmologist before any eye surgery. This is one of the most important and most commonly forgotten drug interactions in urology. The risk persists even if you have since stopped the medication. Learn more about alpha-blocker risks.

Minimally invasive procedures such as UroLift and Rezum have been specifically designed to treat BPH while preserving sexual function. Neither procedure has been shown to cause new-onset erectile dysfunction or ejaculatory dysfunction in clinical trials, making them attractive options for men who prioritize sexual function. See our UroLift and Rezum explainer and discuss these with your urologist if medication side effects are intolerable.